Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumor Lysate or Homogenate Combined With Immunomodulating Radiotherapy and/or Preleukapheresis IFN-alfa in Patients With Metastatic Melanoma: a Randomized "Proof-of-principle" Phase II Study
Clinical trial NCT01973322 · COMPLETED
Trial details
- NCT number
- NCT01973322
- Sponsor
- Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-08
- Primary completion
- 2023-09-30
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.